Nov 11, 2021 / NTS GMT
Operator
Good day, and welcome to the Biotest AG Full Q3 Results 2021 Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Dr. Michael Ramroth. Please go ahead, sir.
Michael Ramroth - Biotest Aktiengesellschaft - Chairman of the Management Board, CEO & CFO
Thank you very much for the nice opening remarks. This is Michael Ramroth. Good morning, everybody, on this cold and foggy day. I would like to extend a very warm welcome to all of you, all of you who are interested in Biotest, its performance in the past and its future, especially with regard to the future. I'm grateful that today, Jörg Schüttrumpf is with me, Head of our R&D project, and he will familiarize you with the progress we have on our R&D projects later on.
But let me start with the most recent activities triggered by Grifols. As you know, Grifols S.A. has on September 17 published that they have reached an agreement with our current major shareholder, the Creat Group, that they would acquire all the shares from Creat. And that, I
Q3 2021 Biotest AG Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot